Kidney dialysis. Y84 Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
Conditions
Interventions
Intervention 1: Intervention group: pentoxifylline. Each patient in the trial group will receive received PTX (400mg twice a day for 12 weeks). Intervention 2: Control group: control group will recei
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: having the age of 18 years and more receiving HD treatments at least for 3 months receiving 4-hour HD treatments 3 times per week a hemoglobin (Hb)<11 in at least 2 consecutive tests in a month no change in EPO dose for at least 1 month before starting the study.
Exclusion criteria
Exclusion criteria: blood transfusion due to any reason in recent 3 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hemoglobin. Timepoint: at the beginning and the end of the study. Method of measurement: blood samples will be drawn to measure of hemoglobin. | — |
Secondary
| Measure | Time frame |
|---|---|
| Erythrocyte sedimentation rate. Timepoint: at the beginning and the end of the study. Method of measurement: blood samples will be drawn.;C-reactive protein. Timepoint: at the beginning and the end of the study. Method of measurement: blood samples will be drawn. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMaryam Pakfetrat
Shiraz University of Medical Sciences
Outcome results
None listed